Myriad Genetics Inc (LTS:0K3W)
$ 2.9 -2.258 (-43.78%) Market Cap: 270.12 Mil Enterprise Value: 365.42 Mil PE Ratio: 0 PB Ratio: 0.89 GF Score: 54/100

Myriad Genetics Inc at TD Cowen Healthcare Conference Transcript

Mar 03, 2026 / 08:10PM GMT
Release Date Price: $5.24 (+4.38%)
Kyle Boucher
Cowen and Company LLC - Equity Analyst

All right, good afternoon, everybody and welcome back to the 46th Annual TD Cowen Healthcare Conference. I'm Kyle Boucher, an analyst in the Life Science and Diagnostic Tools team here, and I'm pleased to be joined by Myriad Genetics. I have Sam Raha, President and CEO; and Ben Wheeler, CFO. Great to have you guys.

Sam Raha
Myriad Genetics Inc - President, Chief Executive Officer, Director

Thanks for having us, Kyle.

Benjamin Wheeler
Myriad Genetics Inc - Chief Financial Officer

Thanks, Kyle.

Questions & Answers

Kyle Boucher
Cowen and Company LLC - Equity Analyst

So maybe just jumping right in, starting with you, Sam. Sam, it's been nearly a year since you took over as CEO on April 30, 2025. So not quite a year, but getting pretty close. Since taking over as CEO, you've gone through a comprehensive review the portfolio you've laid out your strategic priorities across each business unit.

I guess

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot